Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study

Blood (2018) 132 (Supplement 1): 46.

https://doi.org/10.1182/blood-2018-99-113718

Published: 2018

Journal Articles

B3a2 Transcript Is an Independent Factor for the Achievement of a Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Imatinib in First-Line

Matheus Sebastian Da Silva, Eliana C Miranda, Marcia Torresan Delamain, MD, Gislaine Oliveira Duarte, MD, Bruna R Vergilio, Ana Beatriz Pascoal Lopes, Jessica CN Vianna, Carmino Antonio De Souza, MD PhD, Erich Vinicius De Paula, MD PhD, Katia B Pagnano, MD

Blood (2018) 132 (Supplement 1): 1749.

https://doi.org/10.1182/blood-2018-99-114036

Published: 2018

Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Maria Elena Cabrera, Monica Bellei, MSc, PhD, Young Hyeh Ko, MD, Martina Manni, PhD, Steven M. Horwitz, MD, Carmino Antonio De Souza, MD PhD, John A. Radford, MD, Sabela Bobillo Varela, Maria Virginia Prates, MD, Andrés J M Ferreri, MD, Carlos Chiattone, MD, Michele Spina, MD, Julie M. Vose, MDMBA, Annalisa Chiappella, MD, Daniele Laszlo, MD, Dario Marino, MDPhD, Caterina Stelitano, Massimo Federico, MD

Blood (2017) 130 (Supplement 1): 4071.

https://doi.org/10.1182/blood.V130.Suppl_1.4071.4071

Published: 2017

Journal Articles

Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO) — Evaluation of Pioglitazone in Treatment-Free Remission

Katia B Pagnano, MD, Eliana C Miranda, Marcia Torresan Delamain, Gislaine Oliveira Duarte, MD, Bruna Virgilio, Jessica Vianna, Erich Vinicius De Paula, MD PhD, Carmino Antonio De Souza, MD PhD

Blood (2017) 130 (Supplement 1): 1595.

https://doi.org/10.1182/blood.V130.Suppl_1.1595.1595

Published: 2017

Journal Articles

E14a2 and e14a2+e13a2 BCR-ABL Transcripts Are Associated with Earlier Cytogenetic and Molecular Response Rates in CML-CP Treated with Imatinib

Katia B Pagnano, MD, Eliana C Miranda, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD, Nelma D Clementino, MD, Arthur Moellmann-Coelho, MD, Maryanna N Da Silva, Renato Centrone, MD, Monika Conchon, MD, Jaisson Bortolini, MD, Teresa Cristina Bortolheiro, MD, Valquiria Povoa, Luciana Nardinelli, Carmino Antonio De Souza, MD PhD, Israel Bendit, MD PhD

Blood (2017) 130 (Supplement 1): 1596.

https://doi.org/10.1182/blood.V130.Suppl_1.1596.1596

Published: 2017

Journal Articles

VEGF , VEGFR2 and GSTM1 polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era

Leisa Lopes-Aguiar, Marcia Torresan Delamain, Angelo Borsarelli Carvalho Brito, Gustavo Jacob Lourenço, Ericka Francislaine Dias Costa, Gislaine Borba Oliveira, Jose Vassallo, Carmino Antônio De Souza, MD PhD, Carmen Silvia Passos Lima

Blood (2016) 128 (22): 4457.

https://doi.org/10.1182/blood.V128.22.4457.4457

Published: 2016

Journal Articles

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Katia B.B. Pagnano, MD PhD, Eliana Cristina Martins Miranda, PhD, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, MD, Erich Vinicius De Paula, MD PhD, Valquiria Povoa, Bruna Rocha Vergilio, Irene Lorand-Metze, MD PhD, Carmino Antônio De Souza, MD PhD

Blood (2016) 128 (22): 1911.

https://doi.org/10.1182/blood.V128.22.1911.1911

Published: 2016

Journal Articles

Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study

Marcia T Delamain, MD, Eliana Cristina Martins Miranda, PhD, Maria Gomes da Silva, MDPhD, Joana Desterro, MD, Merli Francesco, MD, Carlos Chiattone, MD PhD, Stefano Luminari, MD, Katia BB Pagnano, Carmino Antonio De Souza, MD PhD, Massimo Federico

Blood (2015) 126 (23): 5032.

https://doi.org/10.1182/blood.V126.23.5032.5032

Published: 2015

Journal Articles

Collagen Fibers Structure Detected By Second-Harmonic Generation Microscopy: A Potential Prognostic Marker for High-Risk Nodular Sclerosis

Guilherme Rossi Assis de Mendonça, Rodrigo de Andrade Natal, Bruna de Albuquerque Murbach, Marcia Torresan Delamain, MD, Carmino Antônio De Souza, MD PhD, Carlos Lenz Cesar, PhD, Jose Vassallo, MD PhD

Blood (2015) 126 (23): 5000.

https://doi.org/10.1182/blood.V126.23.5000.5000

Published: 2015

Journal Articles

Pre-Transplant Beta2-Microglobulin Is an Independent Biomarker of Acute Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant in a Single Institutional Study

Carolina Costa-Lima, MD, Eliana Cristina Martins Miranda, PhD, Marcos Paulo Colella, MD, Francisco José Penteado Aranha, MD PhD, Carmino Antônio De Souza, MD PhD, Afonso Celso Vigorito, MD PhD, Erich Vinicius De Paula, MD PhD

Blood (2015) 126 (23): 3152.

https://doi.org/10.1182/blood.V126.23.3152.3152

Published: 2015

Journal Articles

Association of Bax and Bcl-2 polymorphisms in Aggressiveness and Prognosis of Diffuse Large B-Cell Lymphoma

Angelo Borsarelli Carvalho Brito, Cristiane Oliveira, Marcia Toressan Delamain, MD, Carmino Antonio De Souza, MD PhD, José Vassallo, MD PhD, Carmen Silvia Passos Lima, MD PhD

Blood (2014) 124 (21): 3017.

https://doi.org/10.1182/blood.V124.21.3017.3017

Published: 2014

Journal Articles

VEGF 2578 c>a, a Functional Angiogenic Polymorphism, Is Associated with Aggressiveness and Clinical Outcome of Follicular Lymphoma

Guilherme Rossi Assis de Mendonça, Angelo Borsarelli Carvalho Brito, Rodrigo de Andrade Natal, Marcia T Delamain, MD, Carmino Antonio De Souza, MD PhD, Gisele W. B. Colleoni, MD, José Vassallo, MD PhD, Carmen Silvia Passos Lima, MD PhD

Blood (2014) 124 (21): 3022.

https://doi.org/10.1182/blood.V124.21.3022.3022

Published: 2014

Journal Articles

Clinical Characteristics and Outcome of 41 Patients with Upper GI Diffuse B-Cell Non-Hodgkin Lymphoma. Results of Brazilian-Italy Lymphoma Registry

Marcia T Delamain, MD, Eliana C M Miranda, MD PhD, Merli Francesco, MD, Carlos S Chiattone, MD PhD, Anna Fedina, Stefano Luminari, MD, Carmino Antonio De Souza, MD PhD, Federico Massimo, MD

Blood (2014) 124 (21): 5400.

https://doi.org/10.1182/blood.V124.21.5400.5400

Published: 2014

Journal Articles

EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience

Katia B. Pagnano, MD, Irene Lorand-Metze, MD, PhD, Eliana C M Miranda, Vagner O Duarte, Marcia T Delamain, MD, Gislaine O Duarte, MD, Carmino Antonio De Souza, MD, PhD

Blood (2012) 120 (21): 1681.

https://doi.org/10.1182/blood.V120.21.1681.1681

Published: 2012

Journal Articles

The Utilization of NET Promoter System As a Blood Supply Management Strategy

Gustavo De Carvalho Duarte, MD, Erich V de Paula, MD, PhD, Francisco J P Aranha, MD, PhD, Gislaine Borba Oliveira, MD, Afonso Celso Vigorito, MD, PhD, Carmino Antonio De Souza, MD, PhD, José Francisco Marques, PhD

Blood (2012) 120 (21): 4378.

https://doi.org/10.1182/blood.V120.21.4378.4378

Published: 2012

Journal Articles

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Maiara Marx Luz Fiusa, Carolina Costa-Lima, MD, Gleice Regina Souza, Afonso Celso Vigorito, MD, PhD, Francisco J P Aranha, MD, PhD, Irene Lorand-Metze, MD, PhD, Joyce M Annichino-Bizzacchi, MD, PhD, Carmino Antonio De Souza, MD, PhD, Erich V De Paula, MD, PhD

Blood (2012) 120 (21): 2154.

https://doi.org/10.1182/blood.V120.21.2154.2154

Published: 2012

Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Blood (2011) 118 (21): 1701.

https://doi.org/10.1182/blood.V118.21.1701.1701

Published: 2011

Journal Articles

The Alteration of SEPT5 Gene Expression in BCR-ABL Positive Cells and Its Possible Correlation with the Development and / or Progression of Chronic Myeloid Leukemia (CML)

Cintia Do Couto Mascarenhas, MD, PhD, Anderson Ferreira Cunha, Ph.D., Ana Flavia Brugnerotto, Sheley Gambero, B.Sc., M.Sc., Joao Machado-Neto, MSc, Adriana S S Duarte, PhD, Katia B. Pagnano, MD, Fernando Ferreira Costa, MD, PhD, Carmino Antonio De Souza, MD, PhD

Blood (2011) 118 (21): 4415.

https://doi.org/10.1182/blood.V118.21.4415.4415

Published: 2011

Journal Articles

Cytomegalovirus (CMV) gB3 Genotype Is Associated with Acute Gvhd and CMV Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients (HSCT)

Débora de Campos Dieamant, MD, Sandra Helena Alves Bonon, PhD, Francisco J P Aranha, M.D., P.h.D., Gislaine O. Duarte, PhD, Virginio C.O. Fernandes, MD, Carmino Antonio De Souza, MD, PhD, Sandra Cecília Botelho Costa, PhD, Afonso Celso Vigorito, MD, PhD

Blood (2011) 118 (21): 1958.

https://doi.org/10.1182/blood.V118.21.1958.1958

Published: 2011

Journal Articles

Evaluation of Thrombin Generation in the Early Stages of Sepsis in Patients with Hematological Malignancies and Febrile Neutropenia,

Susan K Picoli-Quaino, Brunna E Alves, M.D., P.h.D., Francisco J P Aranha, M.D., P.h.D., Irene Lorand-Metze, MD, PhD, Carmino Antonio De Souza, MD, PhD, Joyce M Annichino-Bizzacchi, MD, PhD, Erich V De Paula, M.D., Ph.D.

Blood (2011) 118 (21): 3347.

https://doi.org/10.1182/blood.V118.21.3347.3347

Published: 2011

NARROW

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study

B3a2 Transcript Is an Independent Factor for the Achievement of a Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Imatinib in First-Line

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO) — Evaluation of Pioglitazone in Treatment-Free Remission

E14a2 and e14a2+e13a2 BCR-ABL Transcripts Are Associated with Earlier Cytogenetic and Molecular Response Rates in CML-CP Treated with Imatinib

VEGF , VEGFR2 and GSTM1 polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study

Collagen Fibers Structure Detected By Second-Harmonic Generation Microscopy: A Potential Prognostic Marker for High-Risk Nodular Sclerosis

Pre-Transplant Beta2-Microglobulin Is an Independent Biomarker of Acute Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant in a Single Institutional Study

Association of Bax and Bcl-2 polymorphisms in Aggressiveness and Prognosis of Diffuse Large B-Cell Lymphoma

VEGF 2578 c>a, a Functional Angiogenic Polymorphism, Is Associated with Aggressiveness and Clinical Outcome of Follicular Lymphoma

Clinical Characteristics and Outcome of 41 Patients with Upper GI Diffuse B-Cell Non-Hodgkin Lymphoma. Results of Brazilian-Italy Lymphoma Registry

EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience

The Utilization of NET Promoter System As a Blood Supply Management Strategy

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

The Alteration of SEPT5 Gene Expression in BCR-ABL Positive Cells and Its Possible Correlation with the Development and / or Progression of Chronic Myeloid Leukemia (CML)

Cytomegalovirus (CMV) gB3 Genotype Is Associated with Acute Gvhd and CMV Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients (HSCT)

Evaluation of Thrombin Generation in the Early Stages of Sepsis in Patients with Hematological Malignancies and Febrile Neutropenia,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only